Unsilencing Silenced Genes by CRISPR/Cas9
News Jul 05, 2016
Inducing neuronal differentiation using CRISPR/Cas9-MMEJ system. Seven days after OLIG2 was switched on, cultured human stem cells started expressing neuronal marker gene (red). (Katayama S. et. al., Angewandte Chemie International Edition, April 15, 2016)
The ability to control gene expression in cells allows scientists to understand gene function and manipulate cell fate. Recently, scientists have developed a revolutionary gene-editing tool, called CRIPSR/Cas9, which employs a system naturally used by bacteria as protection against viruses. The tool allows scientists to precisely add, remove or replace specific parts of DNA. CRISPR/Cas9 is the most efficient, inexpensive and easiest gene-editing tool available to date. However, scientists have not yet managed to effectively use it to activate genes in the cells.
A team, led by Toru Kondo at Hokkaido University’s Institute of Genetic Medicine, has developed a powerful new method that does just that.
Genes in cells have their own switches called promoters. A gene is switched off, or silenced, when its promoter is methylated. The team effectively wanted to turn on a switched-off gene.
They combined a DNA repair mechanism, called MMEJ (microhomology-mediated end-joining), with CRISPR/Cas9. They cut out a methylated promoter using CRISPR/Cas9 and then inserted an unmethylated promoter with MMEJ, replacing the off-switch with an on-switch.
The scientists used this tool on the neural cell gene OLIG2 and the embryonic stem cell gene NANOG to test its efficiency in cultured cells. Within five days, they found evidence that the genes were robustly expressed. When they turned on OLIG2 in cultured human stem cells, the cells differentiated to neurons in seven days with high efficiency.
The scientists also found that their editing tool could be used to activate other silenced promoters. In addition, they found that the system didn’t cause unwanted mutations in other non-targeted genes in the cells. The tool has wide potential to be used to manipulate gene expression, create genetic circuits, or to engineer cell fates.
Genetic Discovery Helps Determine the Difference Between Aggressive & Benign Bone TumorsNews
The first genetic marker for the bone tumor, osteoblastoma, has been discovered. Whole-genome and transcriptome sequencing of human bone tumors revealed that a genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma. The results will help clinicians correctly distinguish benign osteoblastoma tumors from aggressive osteosarcoma tumors and direct the correct treatment.READ MORE
Improved Method for Isolating Extracellular RNANews
In a breakthrough that could lead to powerful new ways to diagnose and track a wide range of medical conditions, scientists at The Rockefeller University have devised an improved method for isolating and identifying tiny fragments of RNA in human blood products.READ MORE